← All sarcoma trials
Recruiting now—Ages 2 Years and up

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Sponsor: Istituto Ortopedico Rizzoli · NCT06243588 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Ewing Sarcoma

What it tests

  • clinical records reviewother

Where it's running1 site

1 international site

  • IRCCS Itituto Ortopedico Rizzoli

    Bologna, BO, Italy 40136

    Recruiting now
    • Costantino Errani, MD(contact)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
* Age ≥ 2 years
* Diagnosis of Ewing Sarcoma
* Patients with available clinical and imaging data

Exclusion Criteria:

* At least one inclusion criterion not met

Updated 2025-03-05 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.